- High-Quality Products for Wholesalers & Distributors
- Address
- 35 Constitution Dr. Suite 1D, Bedford, NH 03110
- Phone Number
- (603) 471-1499
OmniTrust #212 Series Nitrile Powder Free Examination Glove – Chemo Rated
Our OmniTrust Nitrile Powder Free #212 Examination Glove is a thermally activated glove that starts conforming to your hand when donned. You will find our comfort formulation very comfortable, reducing hand fatigue. Chemo Rated and Fentanyl Resistant.
Our OmniTrust Nitrile Powder Free #212 Examination Glove has our famous micro-texture fingertips and matte finish for added grip control without loss of tactile sensitivity. The #212 series is also tested for safe use with chemotherapy drugs, and is fentanyl resistant.
Features/Benefits:
- Comfortable Formulation & Thermally Activated to Reduce Hand Fatigue
- Completely Latex FREE (No Risk for Latex Allergy)
- Tested for Safe Use with Chemo Drugs
- Micro-Textured for Superior Grip Control
- Ambidextrous Beaded Cuff, Single Use Only
- Fentanyl Resistant
Industries:
- Healthcare
- Safety
- Industrial
- Dental
| Order # | Size | Gloves/Box* | Boxes/Case |
| 212-21 | S | 100 | 10 |
| 212-22 | M | 100 | 10 |
| 212-23 | L | 100 | 10 |
| 212-24 | XL | 100 | 10 |
*Packaged by Weight
Powder Free Nitrile Examination Gloves
Not Made with Natural Rubber Latex
Non-Sterile / Finger Textured
Tested for use with Chemotherapy Drugs using ASTM D6978-05
- Gloves used for protection against chemotherapy drug exposure should be selected specifically for the type of drugs being used.
- Users are advised to review Material Safety Data Sheets to determine the required level of protection.
Low Dermatitis Potential
This product demonstrated reduced potential for sensitizing users to chemical additives
Warning:
Do not use this product if you have a known allergy to chemical additives
Not recommended for use with Carmustine and Thiotepa
|
Chemotherapy Drug/Concentration Médicaments de Chimiothérapie/Concentration |
Minimum Breakthrough Detection (Minutes)/ Temps Minimal Avant de Perforer (Minutes) |
| Carmustine(BCNU)(3.3 mg/ml)3,300ppm | 26.2(DO NOT USE) |
| Cisplatin(1.0 mg/ml) 1000ppm | >240 |
| Cyclophosphamide (Cytoxan) (20.0 mg/ml} 20,000ppm | >240 |
| Cytarabine {100 mg/ml) 100,000ppm | >240 |
| Dacarbazine (DTIC) (10.0 mg/ml) 10,000ppm | >240 |
| Doxorublcln Hydrochloride (2.0 mg/ml) 2,000ppm | >240 |
| Etoposide (20.0 mg/ml) 20,000ppm | >240 |
| Fluorouracil (50.0 mg/ml) 50,000ppm | >240 |
| Ifosfamide (50.0 mg/ml) 50,000ppm | >240 |
| Methotrexate {25.0 mg/ml) 25,000ppm | >240 |
| Mitomycin C {0.5 mg/ml) 500ppm | >240 |
| Mitoxantrone {2.0 mg/ml) 2,000ppm | >240 |
| Paclitaxel (Taxol) (6.0 mg/ml) 6,000ppm | >240 |
| Thioptepa (10.0 mg/ml) 10,000ppm | 59.1(DO NOT USE) |
| Vincristine Sulfate (1.0 mg/ml) 1,000ppm | >240 |
| Fentanyl Citrate and Concentration
citrare de fentanyl et concentration |
Minimum Breakthrough Detection Time (Minutes)
Temps minimal avant de perforer (minutes) |
| Fentanyl Citrate Injection (100mcg/2ml) | >240 |
